New Antipsychotics 2025. Total revenues for the first quarter of 2024 were $47.5 million, a 24% decrease compared to $62.5 million for the first quarter of 2023. Feb 10, 2023 7:00 am.
Feb 10, 2023 7:00 am. Drug discovery in the psychiatric arena continues to expand to new domains and conditions previously without.
The Fda Has Approved Two New Medications To Treat Schizophrenia, Including One That Is Also A Treatment For Bipolar Disorder.
Objective to investigate risks of multiple adverse outcomes associated with use of antipsychotics in people with dementia.
Caplyta Q1 2024 Net Product Sales Were $144.8 Million, Compared To $94.7 Million For The Same Period In 2023, Representing A 53% Increase.
It is the first potential new pharmacological approach for treating.
Current Antipsychotics Are Plagued By Patchy Efficacy And Unwanted Side Effects—But A New Treatment Could.
Images References :
With Schizophrenia—Have Lots Of Unpleasant Side Effects.
A new drug compound shows promise for schizophrenia.
December 15, 2023 9:07 Am Est |.
New research urges for policy changes in antipsychotic medication management.
In Its First Phase Three Clinical Test, An Experimental Antipsychotic Medicine Called Lumateperone Has Shown Evidence Of Being Both Effective And Safe.